Orchard Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Blue Owl Capital Holdings LP(0%)
Orchard Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(0%),Deep Track Biotechnology Master Fund, Ltd.(0%), etc.
Orchard Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Blue Owl Capital Holdings LP(6.85%)
Orchard Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(0.0%),Peter Kolchinsky(0.0%), etc.
Orchard Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(0.000%),Abigail P. Johnson(0.000%)
Orchard Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(6.961%),Abigail P. Johnson(6.961%)
Orchard Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Beryl Capital Management LLC(6.9%),Beryl Capital Management LP(6.9%), etc.
Orchard Therapeutics | 15-12G: Notice of termination of registration of a class of securities under Section 12(g) (and amendment thereto)
Orchard Therapeutics | EFFECT: Others
Orchard Therapeutics | EFFECT: Others
Orchard Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Secor Alicia
Orchard Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Rowland Charles A Jr
Orchard Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer THOMAS FRANK E
Orchard Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director GERAGHTY JAMES A
Orchard Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Beck Joanne T.
Orchard Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Gaspar Bobby
Orchard Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Curnutte John T
Orchard Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Altschuler Steven
Orchard Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Dunoyer Marc
Orchard Therapeutics | S-8 POS: S-8 POS
No Data